跳至主要内容
临床试验/IRCT201501041556N71
IRCT201501041556N71已完成2 期

Efficacy of Saffron versus citalopram in the treatment of major depressive disorder, with anxious distress: A double blind randomized controlled trial.

Tehran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • 1-Presence of Major Depressive Disorder, with anxious distress based on DSM-5 criteria; 2- age between 18 to 65 years old; 3-score lower than 20 in Hamilton Rating Scale for depression.
  • Exclusion criteria: 1-Psychotic symptoms; 2-receiving another psychotropic medications; 3-receiving any antidepressants during past one month or ECT during past two months; 4-Presence of hypothyroidism; 5-nursing and pregnant women; 6-srious suicidality during the last year; 7-women who want to be pregnant during the future months; 8-women who are receiving OCP; 9-receiveng aspirin and anticoagulants and NSAIDs.

排除标准

  • 未提供

研究者

相似试验